Surgery Partners (SGRY) Competitors $23.64 +0.42 (+1.81%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$23.68 +0.04 (+0.15%) As of 08/8/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SGRY vs. GH, OPCH, RDNT, BTSG, SHC, CON, WGS, PRVA, ADUS, and PGNYShould you be buying Surgery Partners stock or one of its competitors? The main competitors of Surgery Partners include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Concentra Group Holdings Parent (CON), GeneDx (WGS), Privia Health Group (PRVA), Addus HomeCare (ADUS), and Progyny (PGNY). These companies are all part of the "healthcare" industry. Surgery Partners vs. Its Competitors Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Concentra Group Holdings Parent GeneDx Privia Health Group Addus HomeCare Progyny Surgery Partners (NASDAQ:SGRY) and Guardant Health (NASDAQ:GH) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, media sentiment and profitability. Which has more risk and volatility, SGRY or GH? Surgery Partners has a beta of 1.82, meaning that its share price is 82% more volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Which has higher earnings & valuation, SGRY or GH? Surgery Partners has higher revenue and earnings than Guardant Health. Surgery Partners is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurgery Partners$3.11B0.97-$168.10M-$1.43-16.53Guardant Health$739.02M9.15-$436.37M-$3.35-16.19 Is SGRY or GH more profitable? Surgery Partners has a net margin of -5.57% compared to Guardant Health's net margin of -49.93%. Surgery Partners' return on equity of 2.51% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Surgery Partners-5.57% 2.51% 1.01% Guardant Health -49.93%N/A -28.95% Do insiders & institutionals believe in SGRY or GH? 92.6% of Guardant Health shares are held by institutional investors. 2.3% of Surgery Partners shares are held by insiders. Comparatively, 6.1% of Guardant Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media refer more to SGRY or GH? In the previous week, Guardant Health had 1 more articles in the media than Surgery Partners. MarketBeat recorded 12 mentions for Guardant Health and 11 mentions for Surgery Partners. Guardant Health's average media sentiment score of 0.81 beat Surgery Partners' score of 0.81 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surgery Partners 2 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 6 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate SGRY or GH? Surgery Partners currently has a consensus price target of $33.00, suggesting a potential upside of 39.59%. Guardant Health has a consensus price target of $57.50, suggesting a potential upside of 6.03%. Given Surgery Partners' higher possible upside, equities research analysts clearly believe Surgery Partners is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Surgery Partners 0 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.67Guardant Health 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 1 Strong Buy rating(s) 3.06 SummaryGuardant Health beats Surgery Partners on 9 of the 17 factors compared between the two stocks. Get Surgery Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SGRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SGRY vs. The Competition Export to ExcelMetricSurgery PartnersMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.98B$7.17B$5.44B$9.61BDividend YieldN/A2.85%4.61%4.14%P/E Ratio-16.5365.6629.7524.84Price / Sales0.9730.88449.1298.65Price / Cash12.4025.5336.4258.36Price / Book0.9617.878.185.64Net Income-$168.10M$243.10M$3.26B$265.68M7 Day Performance11.09%2.42%6.88%4.95%1 Month Performance5.58%-3.73%1.00%0.83%1 Year Performance-20.51%18.46%28.85%22.18% Surgery Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SGRYSurgery Partners2.7927 of 5 stars$23.64+1.8%$33.00+39.6%-21.1%$2.98B$3.11B-16.5315,000Positive NewsEarnings ReportGap UpGHGuardant Health2.8616 of 5 stars$44.27-0.3%$54.45+23.0%+79.2%$5.48B$739.02M-13.062,021Gap UpOPCHOption Care Health4.601 of 5 stars$29.77+0.3%$35.50+19.2%-6.1%$4.87B$5.00B24.018,088RDNTRadNet4.1478 of 5 stars$57.83+0.7%$69.60+20.4%-13.5%$4.34B$1.83B-134.4911,021Upcoming EarningsBTSGBrightSpring Health Services2.0299 of 5 stars$20.48-0.2%$24.90+21.6%+80.4%$3.60B$11.27B73.1435,000Earnings ReportAnalyst RevisionSHCSotera Health1.9036 of 5 stars$12.29-0.1%$16.00+30.2%-4.8%$3.49B$1.10B153.643,000Trending NewsEarnings ReportAnalyst ForecastGap UpCONConcentra Group Holdings Parent3.0545 of 5 stars$20.05+2.0%$28.50+42.1%-6.4%$2.57B$1.93B14.9611,250News CoverageEarnings ReportDividend AnnouncementGap UpWGSGeneDx3.0752 of 5 stars$84.91+6.4%$92.33+8.7%+220.2%$2.42B$305.45M-60.221,200Positive NewsPRVAPrivia Health Group3.7513 of 5 stars$19.70-0.1%$28.38+44.1%+6.4%$2.40B$1.74B164.181,140News CoverageEarnings ReportADUSAddus HomeCare4.9089 of 5 stars$109.11-0.3%$142.57+30.7%-11.5%$2.01B$1.21B24.6349,703News CoveragePositive NewsEarnings ReportAnalyst ForecastPGNYProgyny1.7318 of 5 stars$23.20+0.4%$24.82+7.0%+9.0%$1.99B$1.21B40.70310Trending NewsEarnings ReportAnalyst ForecastGap Up Related Companies and Tools Related Companies Guardant Health Competitors Option Care Health Competitors RadNet Competitors BrightSpring Health Services Competitors Sotera Health Competitors Concentra Group Holdings Parent Competitors GeneDx Competitors Privia Health Group Competitors Addus HomeCare Competitors Progyny Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SGRY) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredFOUR TRILLION DOLLARS!Nvidia just became the first company in history to hit a $4 trillion valuation—surpassing Apple and Microsoft....Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surgery Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SGRY Stock Alerts